Abstract 15 — Lupus Low Disease Activity State: An Underutilised Clinical Target that is Attainable and Protective against Lupus Nephritis Relapse
Background Lupus nephritis (LN) is a significant comorbidity affecting approximately 50-60% of patients with systemic lupus erythematosus (SLE). Complete and partial renal response (CRR/PRR) have been recommended as treatment targets in LN. Lupus low disease activity state (LLDAS) is also associated...
Main Authors: | Chak Kwan Cheung, Chak Sing Lau, Shirley Chiu Wai Chan |
---|---|
Format: | Article |
Sprog: | English |
Udgivet: |
World Scientific Publishing
2023-11-01
|
Serier: | Journal of Clinical Rheumatology and Immunology |
Online adgang: | https://www.worldscientific.com/doi/10.1142/S2661341723740310 |
Lignende værker
-
LP-175 Frequencies, clinical characteristics and prognosis of patients with neuropsychiatric systemic lupus erythematosus
af: Chak Sing Lau, et al.
Udgivet: (2023-07-01) -
Efficacy and Safety of Vaccinations in Systemic Lupus Erythematosus
af: Philip Hei Li, et al.
Udgivet: (2020-07-01) -
Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
af: Desmond Y.H. Yap, et al.
Udgivet: (2022-03-01) -
B Cell Subsets and Cellular Signatures and Disease Relapse in Lupus Nephritis
af: Desmond Y. H. Yap, et al.
Udgivet: (2020-09-01) -
Lupus nephritis flare in young patients: relapse or nonadherence to treatment?
af: Rivera F, et al.
Udgivet: (2014-03-01)